Medivolve Announces Telehealth Platform Development Contract and Change of Officers and Directors
16 Gennaio 2024 - 3:00AM
Medivolve Inc. (“
Medivolve” or the
“
Company”) (NEO: MEDV; OTC: MEDVF; FRA:4NC) is
pleased to announce that it has entered into a master services
agreement dated December 29, 2023, with Engineer.ai Corp. (dba
Builder.ai) (“
Builder”) to assist in the
development of its telehealth platform. Pursuant to the agreement,
Builder will develop robust features of the platform, including but
not limited to, provider and patient interfacing, telehealth video
conferencing, appointment scheduling and management tools, credit
card payment processing and more. Features of the platform aim to
additionally integrate through Company API interfaces and
third-party API interfaces, all in compliance with HIPAA (Health
Insurance Portability and Accountability Act). The Company
anticipates that development of the telehealth platform will be
substantially complete within seven months.
Additionally, the Company announces today that
Aaron Atin, Daniyal Baizak and Peter Michel have resigned from
their positions as corporate secretary, director and chief
financial officer of the Company, respectively, effective January
10, 2024, January 12, 2024 and January 15, 2024. Mr. Atin will
continue to support the Company in his capacity as a consultant.
The board and management thank Messrs. Atin, Baizak, and Michel for
their services and contributions and wish them well in their future
endeavours.
About Medivolve
Medivolve is a Canadian healthcare
technology company headquartered in Toronto, Canada. The Company’s
mission is to improve health and lives by delivering world-class
diagnostic solutions—starting with COVID-19—as well as to enable
faster and better care to patients through innovative technology.
Medivolve, through its subsidiaries, operates retail patient-care
locations in California.
For investing inquiries, please
contact: David Preiner, CEO, info@medivolve.ca,
702-990-3737.
Cautionary Note Regarding
Forward-looking Information
This press release contains "forward-looking
information" within the meaning of applicable Canadian securities
legislation. Forward-looking information includes, but is not
limited to, statements with respect to the development of the
telehealth platform, including its features and timeline to
completion. Generally, forward-looking information can be
identified by the use of forward-looking terminology such as
"plans", "expects" or "does not expect", "is expected", "budget",
"scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words
and phrases or state that certain actions, events or results "may",
"could", "would", "might" or "will be taken", "occur" or "be
achieved". Forward-looking information is subject to known and
unknown risks, uncertainties and other factors that may cause the
actual results, level of activity, performance or achievements of
the Company, as the case may be, to be materially different from
those expressed or implied by such forward-looking information,
including (but not limited to): uncertainties relating to the
demand for a telehealth platform; the Company’s and Builder’s
ability to develop the telehealth platform; risks inherent to the
technological industry, including the emergence of disruptive
technologies that may impact the demand for the telehealth
platform; receipt of necessary approvals; general business,
economic, competitive, political and social uncertainties;
accidents, labour disputes and shortages and other risks of the
healthcare and medical-related industries, and the other risk
factors discussed in the Company’s most recent annual information
form and management’s discussion and analysis, available on SEDAR+
at www.sedarplus.ca. Although the Company has attempted to identify
important factors that could cause actual results to differ
materially from those contained in forward-looking information,
there may be other factors that cause results not to be as
anticipated, estimated or intended. There can be no assurance that
such information will prove to be accurate, as actual results and
future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue
reliance on forward-looking information. The Company does not
undertake to update any forward-looking information, except in
accordance with applicable securities laws.
Grafico Azioni Medivolve (NEO:MEDV)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Medivolve (NEO:MEDV)
Storico
Da Nov 2023 a Nov 2024